| 1 |
32884297 | MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway. | 2020 |
3 |
| 2 |
31035526 | Effects of β-Adrenergic Antagonists on Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. | 2019 Apr 26 |
1 |
| 3 |
31387179 | Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer. | 2019 Sep |
1 |
| 4 |
31686855 | Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin. | 2019 |
3 |
| 5 |
29344283 | Antigen presentation of the Oct4 and Sox2 peptides by CD154-activated B lymphocytes enhances the killing effect of cytotoxic T lymphocytes on tumor stem-like cells derived from cisplatin-resistant lung cancer cells. | 2018 |
2 |
| 6 |
29393480 | Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition. | 2018 Apr |
1 |
| 7 |
29088858 | Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism. | 2017 Sep 26 |
1 |
| 8 |
29137407 | LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer. | 2017 Oct 13 |
1 |
| 9 |
31966561 | β-catenin inhibitors suppress cells proliferation and promote cells apoptosis in PC9 lung cancer stem cells. | 2017 |
1 |
| 10 |
27581532 | Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy. | 2016 Nov |
1 |
| 11 |
26622574 | Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells. | 2015 Aug |
7 |
| 12 |
22473092 | An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles. | 2012 Jul |
1 |
| 13 |
20372796 | Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer. | 2010 May |
1 |
| 14 |
19173824 | [Sensitivity of two cell lines with acquired resistance to gefitinib to several chemotherapeutic drugs]. | 2008 Nov |
3 |
| 15 |
12367792 | Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines. | 2002 Oct |
1 |
| 16 |
10194555 | Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines. | 1999 Jan |
1 |
| 17 |
10394958 | Up-regulation of ICH-1L protein by thromboxane A2 antagonists enhances cisplatin-induced apoptosis in non-small-cell lung-cancer cell lines. | 1999 Jul |
3 |
| 18 |
8692539 | Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines. | 1996 Jul-Aug |
2 |
| 19 |
7499442 | In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c/t curve. | 1995 |
1 |
| 20 |
7866991 | In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines. | 1995 Mar 1 |
3 |
| 21 |
7872708 | Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines. | 1994 Nov-Dec |
3 |
| 22 |
8071107 | Rapid polymerase chain reaction assay to detect variation in the extent of gene-specific damage between cisplatin- or VP-16-resistant and sensitive lung cancer cell lines. | 1994 Jul |
4 |
| 23 |
1310490 | Increased phosphorylation of nuclear phosphoproteins in human lung-cancer cells resistant to cis-diamminedichloroplatinum (II). | 1992 Feb 1 |
4 |
| 24 |
1400562 | Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. | 1992 |
4 |
| 25 |
1569201 | Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by cis-diamminedichloroplatinum(II). | 1992 May |
1 |
| 26 |
2116401 | Determinants of drug response in a cisplatin-resistant human lung cancer cell line. | 1990 May |
3 |
| 27 |
2206949 | Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin. | 1990 Sep |
1 |
| 28 |
2369137 | [Combination effect of caffeine and cisplatin on a cisplatin resistant human lung cancer cell line]. | 1990 Jul |
4 |
| 29 |
4094096 | Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay. | 1985 Dec |
1 |